GE HealthCare Technologies Inc. is expected to release its Q3 2026 10-Q filing on October 26, 2026. Last quarter: In 2026-Q2, GE HealthCare reported total revenues of $5.295B (up 5.8% YoY) and net income of $561M ($1.24 diluted EPS), driven by strong demand in its newly formed Advanced Imaging Solutions segment and the strategic acquisition of Intelerad.
EPS Estimate
$1.27
Revenue Estimate
$5.52B
Analyst consensus from Finnhub. Actual results posted within minutes of the SEC filing on the GEHC page.
Drawn from management commentary in the Q2 2026 10-Q:
In 2026-Q2, GE HealthCare combined its Imaging and Advanced Visualization Solutions businesses into a new reportable segment named Advanced Imaging Solutions (AIS), bringing its reportable segments to three: AIS, Pharmaceutical Diagnostics (PDx), and Patient Care Solutions (PCS).
On March 18, 2026, the company acquired 100% of Intelerad for approximately $2.293B in cash to expand its medical imaging software and digital enterprise workflow capabilities within the AIS segment.
Total revenues for 2026-Q2 reached $5.295B, up 5.8% from $5.007B in 2025-Q2. Net income attributable to GE HealthCare grew 15.4% YoY to $561M, while diluted EPS increased 17.0% to $1.24.
Add GEHC to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.